Cardiff Oncology, Inc. (CRDF) Financials
CRDF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 37.3 million | 10.8 million |
| March 31, 2026 | 49.2 million | 14.5 million |
| Dec. 31, 2025 | 61.9 million | 16.5 million |
| Sept. 30, 2025 | 63.8 million | 15.0 million |
CRDF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -11.8 million | 920000 |
| March 31, 2026 | -12.3 million | 1.7 million |
| Dec. 31, 2025 | -6.0 million | 1.3 million |
| Sept. 30, 2025 | -10.9 million | 1.4 million |
CRDF Net Income
No data available :(
CRDF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 34.5 million | - | 457000 |
| March 31, 2026 | 46.1 million | - | 646000 |
| Dec. 31, 2025 | 58.3 million | - | 832000 |
| Sept. 30, 2025 | 60.6 million | - | 1.0 million |
CRDF Shares Outstanding
CRDF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 44000 | 5.9 million | 3.8 million | - |
| March 31, 2026 | - | 6.8 million | 6.1 million | - |
| Dec. 31, 2025 | - | 5.1 million | 3.0 million | - |
| Sept. 30, 2025 | 18000 | 8.2 million | 3.9 million | - |
CRDF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 104000 | - |
| March 31, 2026 | 41000 | 221000 |
| Dec. 31, 2025 | 243000 | 223000 |
| Sept. 30, 2025 | 120000 | - |
CRDF Revenue by Segment
Graph available only for paid members. Upgrade to see it.
CRDF
Price: $1
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.57 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 531000
Market Capitalization: 87.9 million